RLAY FY 2022 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-54.4% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$299M-21670.9% margin

Net Income

-$291M-21036.1% margin

EPS (Diluted)

$-2.59

Cash Flow

Operating Cash Flow

-$229M

Free Cash Flow

-$239M

Stock-Based Comp.

$56M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$150M

Stockholders' Equity

$950M

Cash & Equivalents

$999M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$3M	-54.4%
Gross Profit	$1M	$3M	-54.4%
Operating Income	-$299M	-$365M	+17.9%
Net Income	-$291M	-$364M	+20.2%